Berkshire Capital Holdings Inc Repligen Corp Transaction History

Berkshire Capital Holdings Inc

  • $233 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $12.8 Million - $15.7 Million
-51,520 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $10 Million - $16.7 Million
51,520 New
51,520 $14.9 Million

Others Institutions Holding RGEN

# of Institutions
492
Shares Held
53.7M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Berkshire Capital Holdings Inc Portfolio

Follow Berkshire Capital Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Capital Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Capital Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email